Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jensen, H; Orskov, C; Rehfeld, JF; Johnsen, AH
   A processing enzyme cleaving avian progastrin at post-Phe bonds
   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
   
   H. Jensen et al., "A processing enzyme cleaving avian progastrin at post-Phe bonds", BBA-PROT ST, 1547(1), 2001, pp. 64-71
2. Thulesen, J; Hartman, B; Kissow, H; Jeppsen, PK; Orskov, C; Holst, JJ; Poulsen, SS
   Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection
   DIGESTIVE DISEASES AND SCIENCES
   
   J. Thulesen et al., "Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection", DIG DIS SCI, 46(2), 2001, pp. 379-388
3. Holst, JJ; Orskov, C
   Incretin hormones - an update
   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
   
   J.J. Holst e C. Orskov, "Incretin hormones - an update", SC J CL INV, 61, 2001, pp. 75-85
4. Sams-Nielsen, A; Orskov, C; Jansen-Olesen, I
   Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals
   BRITISH JOURNAL OF PHARMACOLOGY
   
   A. Sams-Nielsen et al., "Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals", BR J PHARM, 132(5), 2001, pp. 1145-1153
5. Thulesen, J; Hartmann, B; Orskov, C; Jeppesen, PB; Holst, JJ; Poulsen, SS
   Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2
   PEPTIDES
   
   J. Thulesen et al., "Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2", PEPTIDES, 21(10), 2000, pp. 1511-1517
6. Hartmann, B; Johnsen, AH; Orskov, C; Adelhorst, K; Thim, L; Holst, JJ
   Structure, measurement, and secretion of human glucagon-like peptide-2
   PEPTIDES
   
   B. Hartmann et al., "Structure, measurement, and secretion of human glucagon-like peptide-2", PEPTIDES, 21(1), 2000, pp. 73-80
7. Hartmann, B; Thulesen, J; Kissow, H; Thulesen, S; Orskov, C; Ropke, C; Poulsen, SS; Holst, JJ
   Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice
   ENDOCRINOLOGY
   
   B. Hartmann et al., "Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice", ENDOCRINOL, 141(11), 2000, pp. 4013-4020
8. Hansen, L; Deacon, CF; Orskov, C; Holst, JJ
   Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine
   ENDOCRINOLOGY
   
   L. Hansen et al., "Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine", ENDOCRINOL, 140(11), 1999, pp. 5356-5363
9. HJORTH SA; ORSKOV C; SCHWARTZ TW
   CONSTITUTIVE ACTIVITY OF GLUCAGON RECEPTOR MUTANTS
   Molecular endocrinology
   
   S.A. Hjorth et al., "CONSTITUTIVE ACTIVITY OF GLUCAGON RECEPTOR MUTANTS", Molecular endocrinology, 12(1), 1998, pp. 78-86
10. NAUCK MA; WEBER I; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
    NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS
    Diabetic medicine
    
    M.A. Nauck et al., "NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS", Diabetic medicine, 15(11), 1998, pp. 937-945
11. HOLST JJ; HANSEN L; ORSKOV C; WOJDEMANN M; WETIERGREN A; DEACON CF
    GLP-1 (7-36AMIDE) IS TRANSFORMED BY DIPEPTIDYL PEPTIDASE-IV IN THE CAPILLARIES SUPPLYING THE L-CELLS INTO GLP-1 (9-36AMIDE), WHICH ANTAGONIZES THE GASTROINTESTINAL EFFECTS OF GLP-1
    Diabetes
    
    J.J. Holst et al., "GLP-1 (7-36AMIDE) IS TRANSFORMED BY DIPEPTIDYL PEPTIDASE-IV IN THE CAPILLARIES SUPPLYING THE L-CELLS INTO GLP-1 (9-36AMIDE), WHICH ANTAGONIZES THE GASTROINTESTINAL EFFECTS OF GLP-1", Diabetes, 47, 1998, pp. 115-115
12. LARSEN PJ; TANGCHRISTENSEN M; HOLST JJ; ORSKOV C
    DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 AND OTHER PREPROGLUCAGON-DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM
    Neuroscience
    
    P.J. Larsen et al., "DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 AND OTHER PREPROGLUCAGON-DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM", Neuroscience, 77(1), 1997, pp. 257-270
13. NAUCK MA; NIEDEREICHHOLZ U; ETTLER R; HOLST JJ; ORSKOV C; RITZEL R; SCHMIEGEL WH
    GLUCAGON-LIKE PEPTIDE-1 INHIBITION OF GASTRIC-EMPTYING OUTWEIGHS ITS INSULINOTROPIC EFFECTS IN HEALTHY HUMANS
    American journal of physiology: endocrinology and metabolism
    
    M.A. Nauck et al., "GLUCAGON-LIKE PEPTIDE-1 INHIBITION OF GASTRIC-EMPTYING OUTWEIGHS ITS INSULINOTROPIC EFFECTS IN HEALTHY HUMANS", American journal of physiology: endocrinology and metabolism, 36(5), 1997, pp. 981-988
14. HOLST A; ORSKOV C; WETTERGREN AW; WOJDEMANN M
    INTESTINAL ENDOCRINE SIGNALS TO THE CNS
    Gut
    
    A. Holst et al., "INTESTINAL ENDOCRINE SIGNALS TO THE CNS", Gut, 41, 1997, pp. 42-43
15. NAUCK MA; KEMMERIES G; GROSSER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
    RAPID TACHYPHYLAXIS FOR THE DECELERATION OF GASTRIC-EMPTYING BY EXOGENOUS GLP-1
    Gastroenterology
    
    M.A. Nauck et al., "RAPID TACHYPHYLAXIS FOR THE DECELERATION OF GASTRIC-EMPTYING BY EXOGENOUS GLP-1", Gastroenterology, 112(4), 1997, pp. 797-797
16. THULESEN J; ORSKOV C; HOLST JJ; POULSEN SS
    SHORT-TERM INSULIN-TREATMENT PREVENTS THE DIABETOGENIC ACTION OF STREPTOZOTOCIN IN RATS
    Endocrinology
    
    J. Thulesen et al., "SHORT-TERM INSULIN-TREATMENT PREVENTS THE DIABETOGENIC ACTION OF STREPTOZOTOCIN IN RATS", Endocrinology, 138(1), 1997, pp. 62-68
17. CREUTZFELDT WOC; ORSKOV C; KLEINE N; HOLST JJ; WILLMS B; NAUCK MA
    GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS
    Diabetes care
    
    W.O.C. Creutzfeldt et al., "GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS", Diabetes care, 19(6), 1996, pp. 580-586
18. NAUCK MA; SIEMSGLUSS J; ORSKOV C; HOLST JJ
    RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36-AMIDE]), GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND INSULIN IN RESPONSE TO ORAL GLUCOSE AFTERUPPER AND LOWER INTESTINAL RESECTIONS
    Zeitschrift fur Gastroenterologie
    
    M.A. Nauck et al., "RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36-AMIDE]), GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND INSULIN IN RESPONSE TO ORAL GLUCOSE AFTERUPPER AND LOWER INTESTINAL RESECTIONS", Zeitschrift fur Gastroenterologie, 34(3), 1996, pp. 159-166
19. ORSKOV C; WETTERGREN A; HOLST JJ
    SECRETION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE CORRELATES WITH INSULIN-SECRETION IN NORMAL MAN THROUGHOUT THE DAY
    Scandinavian journal of gastroenterology
    
    C. Orskov et al., "SECRETION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE CORRELATES WITH INSULIN-SECRETION IN NORMAL MAN THROUGHOUT THE DAY", Scandinavian journal of gastroenterology, 31(7), 1996, pp. 665-670
20. WILLMS B; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; NAUCK MA
    GASTRIC-EMPTYING GLUCOSE RESPONSES, AND INSULIN-SECRETION AFTER A LIQUID TEST MEAL - EFFECTS OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)-(7-36) AMIDE IN TYPE-2 (NONINSULIN-DEPENDENT) DIABETIC-PATIENTS
    The Journal of clinical endocrinology and metabolism
    
    B. Willms et al., "GASTRIC-EMPTYING GLUCOSE RESPONSES, AND INSULIN-SECRETION AFTER A LIQUID TEST MEAL - EFFECTS OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)-(7-36) AMIDE IN TYPE-2 (NONINSULIN-DEPENDENT) DIABETIC-PATIENTS", The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 327-332
21. NAUCK MA; GROSSER S; KEMMERIES G; ORSKOV C; HOLST JJ; SCHMIEGEL W
    ERYTHROMYCIN, BUT NOT METOCLOPRAMIDE, DOMPERIDONE, OR CISAPRIDE ANTAGONIZE THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 IN HEALTHY-VOLUNTEERS
    Gastroenterology
    
    M.A. Nauck et al., "ERYTHROMYCIN, BUT NOT METOCLOPRAMIDE, DOMPERIDONE, OR CISAPRIDE ANTAGONIZE THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 IN HEALTHY-VOLUNTEERS", Gastroenterology, 110(4), 1996, pp. 723-723
22. NAUCK MA; NIEDEREICHHOLZ U; ETTLER R; ORSKOV C; HOLST JJ; SCHMIEGEL W
    EVIDENCE AGAINST A PHYSIOLOGICAL-ROLE OF GLP-1 AS AN INSULINOTROPIC INCRETIN HORMONE IN HEALTHY-VOLUNTEERS
    Gastroenterology
    
    M.A. Nauck et al., "EVIDENCE AGAINST A PHYSIOLOGICAL-ROLE OF GLP-1 AS AN INSULINOTROPIC INCRETIN HORMONE IN HEALTHY-VOLUNTEERS", Gastroenterology, 110(4), 1996, pp. 1103-1103
23. NAUCK MA; WOLLSCHLAGER D; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; WILLMS B
    EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36 AMIDE]) IN PATIENTS WITH NIDDM
    Diabetologia
    
    M.A. Nauck et al., "EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36 AMIDE]) IN PATIENTS WITH NIDDM", Diabetologia, 39(12), 1996, pp. 1546-1553
24. ORSKOV L; HOLST JJ; MOLLER J; ORSKOV C; MOLLER N; ALBERTI KGMM; SCHMITZ O
    GLP-1 DOES NOT ACUTELY AFFECT INSULIN SENSITIVITY IN HEALTHY MAN
    Diabetologia
    
    L. Orskov et al., "GLP-1 DOES NOT ACUTELY AFFECT INSULIN SENSITIVITY IN HEALTHY MAN", Diabetologia, 39(10), 1996, pp. 1227-1232
25. NAUCK MA; GROSSER S; KEMMERIES G; ORSKOV C; HOLST JJ; SCHMIEGEL W
    ERYTHROMYCIN ANTAGONIZES THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 AND UNMASKS IT POSTPRANDIAL INSULINOTROPIC ACROSS
    Diabetologia
    
    M.A. Nauck et al., "ERYTHROMYCIN ANTAGONIZES THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 AND UNMASKS IT POSTPRANDIAL INSULINOTROPIC ACROSS", Diabetologia, 39, 1996, pp. 591-591
26. ORSKOV C; POULSEN SS; MOLLER M; HOLST JJ
    GLUCAGON-LIKE PEPTIDE-I RECEPTORS IN THE SUBFORNICAL ORGAN AND THE AREA POSTREMA ARE ACCESSIBLE TO CIRCULATING GLUCAGON-LIKE PEPTIDE-I
    Diabetes
    
    C. Orskov et al., "GLUCAGON-LIKE PEPTIDE-I RECEPTORS IN THE SUBFORNICAL ORGAN AND THE AREA POSTREMA ARE ACCESSIBLE TO CIRCULATING GLUCAGON-LIKE PEPTIDE-I", Diabetes, 45(6), 1996, pp. 832-835
27. ORSKOV C; TANGCHRISTENSEN M; HOLST JJ; LARSEN PJ
    DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AND OTHER PREPROGLUCAGON DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM
    Diabetes
    
    C. Orskov et al., "DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AND OTHER PREPROGLUCAGON DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM", Diabetes, 45, 1996, pp. 546-546
28. HEINZE E; HOLL RW; CLARK PMS; HALES CN; ORSKOV C; EBERT R
    THE ENTEROINSULAR AXIS IN WOMEN WITH TURNER-SYNDROME (TS) AND NORMAL ORAL GLUCOSE-TOLERANCE
    Diabetes
    
    E. Heinze et al., "THE ENTEROINSULAR AXIS IN WOMEN WITH TURNER-SYNDROME (TS) AND NORMAL ORAL GLUCOSE-TOLERANCE", Diabetes, 45, 1996, pp. 1116-1116
29. HARTMANN B; JOHNSEN AH; ORSKOV C; HOLST JJ
    STRUCTURE, ANALYSIS AND SECRETION OF HUMAN GLUCAGON-LIKE PEPTIDE-2 (GLP-2)
    Diabetes
    
    B. Hartmann et al., "STRUCTURE, ANALYSIS AND SECRETION OF HUMAN GLUCAGON-LIKE PEPTIDE-2 (GLP-2)", Diabetes, 45, 1996, pp. 1117-1117
30. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
    INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS
    Acta diabetologica
    
    C. Qualmann et al., "INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS", Acta diabetologica, 32(1), 1995, pp. 13-16
31. FIESELER P; BRIDENBAUGH S; NUSTEDE R; MARTELL J; ORSKOV C; HOLST JJ; NAUCK MA
    PHYSIOLOGICAL AUGMENTATION OF AMINO ACID-INDUCED INSULIN-SECRETION BYGIP AND GLP-I BUT NOT BY CCK-8
    American journal of physiology: endocrinology and metabolism
    
    P. Fieseler et al., "PHYSIOLOGICAL AUGMENTATION OF AMINO ACID-INDUCED INSULIN-SECRETION BYGIP AND GLP-I BUT NOT BY CCK-8", American journal of physiology: endocrinology and metabolism, 31(5), 1995, pp. 949-955
32. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
    GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)
    Scandinavian journal of gastroenterology
    
    C. Qualmann et al., "GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)", Scandinavian journal of gastroenterology, 30(9), 1995, pp. 892-896
33. RITZEL R; ORSKOV C; HOLST JJ; NAUCK MA
    PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1 [7-36-AMIDE] AFTER SUBCUTANEOUS INJECTION IN HEALTHY-VOLUNTEERS - DOSE-RESPONSE-RELATIONSHIPS
    Diabetologia
    
    R. Ritzel et al., "PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1 [7-36-AMIDE] AFTER SUBCUTANEOUS INJECTION IN HEALTHY-VOLUNTEERS - DOSE-RESPONSE-RELATIONSHIPS", Diabetologia, 38(6), 1995, pp. 720-725
34. NAUCK MA; WOLLSCHLAGER D; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; WILLMS B
    EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1[7-36 AMIDE]) IN PATIENTS WITH TYPE-2-DIABETES
    Diabetologia
    
    M.A. Nauck et al., "EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1[7-36 AMIDE]) IN PATIENTS WITH TYPE-2-DIABETES", Diabetologia, 38, 1995, pp. 39-39
35. ORSKOV C; WETTERGREN A; POULSEN SS; HOLST JJ
    IS THE EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GASTRIC-EMPTYING CENTRALLY MEDIATED
    Diabetologia
    
    C. Orskov et al., "IS THE EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GASTRIC-EMPTYING CENTRALLY MEDIATED", Diabetologia, 38, 1995, pp. 39-39
36. RITZEL R; ORSKOV C; HOLST JJ; SCHMIEGEL W; NAUCK M
    GLP-1 [7-36 AMIDE] AUGMENTS BIPHASIC INSULIN-SECRETION AFTER INTRAVENOUS GLUCOSE IN HEALTHY-VOLUNTEERS
    Diabetologia
    
    R. Ritzel et al., "GLP-1 [7-36 AMIDE] AUGMENTS BIPHASIC INSULIN-SECRETION AFTER INTRAVENOUS GLUCOSE IN HEALTHY-VOLUNTEERS", Diabetologia, 38, 1995, pp. 39-39
37. WILLMS B; KLEINE N; CREUTZFELDT W; ORSKOV C; HOLST J; NAUCK M
    GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) LOWERS BLOOD-GLUCOSE ALSO IN TYPE-1 DIABETIC-PATIENTS
    Diabetologia
    
    B. Willms et al., "GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) LOWERS BLOOD-GLUCOSE ALSO IN TYPE-1 DIABETIC-PATIENTS", Diabetologia, 38, 1995, pp. 40-40
38. HARTMANN B; ORSKOV C; WETTERGREN A; HOLST JJ
    DIURNAL PROFILES OF GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-2 (GLP-1 AND GLP-2) IN NORMAL MAN
    Diabetologia
    
    B. Hartmann et al., "DIURNAL PROFILES OF GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-2 (GLP-1 AND GLP-2) IN NORMAL MAN", Diabetologia, 38, 1995, pp. 167-167
39. ORSKOV L; HOLST JJ; MOLLER J; ORSKOV C; MOLLER N; SCHMITZ O
    ACUTE GLP-1 ADMINISTRATION DOES NOT AFFECT INSULIN SENSITIVITY IN HEALTHY MAN
    Diabetologia
    
    L. Orskov et al., "ACUTE GLP-1 ADMINISTRATION DOES NOT AFFECT INSULIN SENSITIVITY IN HEALTHY MAN", Diabetologia, 38, 1995, pp. 168-168
40. MINEO H; SCHMIDT P; ORSKOV C; HOLST JJ
    EFFECTS OF LUMINAL STIMULI ON GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-YY RELEASE FROM THE ISOLATED-PERFUSED PIG ILEUM
    Diabetologia
    
    H. Mineo et al., "EFFECTS OF LUMINAL STIMULI ON GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-YY RELEASE FROM THE ISOLATED-PERFUSED PIG ILEUM", Diabetologia, 38, 1995, pp. 170-170
41. WEBER I; BACHESSER AK; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W; NAUCK MA
    PROLONGED NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 (]7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS
    Diabetologia
    
    I. Weber et al., "PROLONGED NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 (]7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS", Diabetologia, 38, 1995, pp. 171-171
42. WETTERGREN A; PETERSEN H; ORSKOV C; CHRISTIANSEN J; SHEIKH SP; HOLST JJ
    GLUCAGON-LIKE PEPTIDE-1 7-36-AMIDE AND PEPTIDE-YY FROM THE L-CELL OF THE ILEAL-MUCOSA ARE POTENT INHIBITORS OF VAGALLY INDUCED GASTRIC-ACIDSECRETION IN MAN
    Scandinavian journal of gastroenterology
    
    A. Wettergren et al., "GLUCAGON-LIKE PEPTIDE-1 7-36-AMIDE AND PEPTIDE-YY FROM THE L-CELL OF THE ILEAL-MUCOSA ARE POTENT INHIBITORS OF VAGALLY INDUCED GASTRIC-ACIDSECRETION IN MAN", Scandinavian journal of gastroenterology, 29(6), 1994, pp. 501-505
43. HVIDBERG A; NIELSEN MT; HILSTED J; ORSKOV C; HOLST JJ
    EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (PROGLUCAGON 78-107AMIDE) ON HEPATIC GLUCOSE-PRODUCTION IN HEALTHY MAN
    Metabolism, clinical and experimental
    
    A. Hvidberg et al., "EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (PROGLUCAGON 78-107AMIDE) ON HEPATIC GLUCOSE-PRODUCTION IN HEALTHY MAN", Metabolism, clinical and experimental, 43(1), 1994, pp. 104-108
44. HOLST JJ; BERSANI M; JOHNSEN AH; KOFOD H; HARTMANN B; ORSKOV C
    PROGLUCAGON PROCESSING IN PORCINE AND HUMAN PANCREAS
    The Journal of biological chemistry
    
    J.J. Holst et al., "PROGLUCAGON PROCESSING IN PORCINE AND HUMAN PANCREAS", The Journal of biological chemistry, 269(29), 1994, pp. 18827-18833
45. ANDREASEN JJ; ORSKOV C; HOLST JJ
    SECRETION OF GLUCAGON-LIKE PEPTIDE-1 AND REACTIVE HYPOGLYCEMIA AFTER PARTIAL GASTRECTOMY
    Digestion
    
    J.J. Andreasen et al., "SECRETION OF GLUCAGON-LIKE PEPTIDE-1 AND REACTIVE HYPOGLYCEMIA AFTER PARTIAL GASTRECTOMY", Digestion, 55(4), 1994, pp. 221-228
46. RITZEL R; ORSKOV C; HOLST JJ; NAUCK MA
    PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1-[7-36 AMIDE] AFTER SC INJECTION IN HEALTHY-VOLUNTEERS
    Diabetologia
    
    R. Ritzel et al., "PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1-[7-36 AMIDE] AFTER SC INJECTION IN HEALTHY-VOLUNTEERS", Diabetologia, 37, 1994, pp. 10000072-10000072
47. NAUCK M; ERPENSTEIN A; HOLST JJ; ORSKOV C; VONBOXBERG C; WIRTZ G; TILLIL H; KOBBERLING J; CREUTZFELDT W
    RELEASE OF GLP-1-[7-36 AMIDE] AFTER ORAL GLUCOSE IN RELATION TO GLUCOSE-TOLERANCE AND SEX
    Diabetologia
    
    M. Nauck et al., "RELEASE OF GLP-1-[7-36 AMIDE] AFTER ORAL GLUCOSE IN RELATION TO GLUCOSE-TOLERANCE AND SEX", Diabetologia, 37, 1994, pp. 10000118-10000118
48. WILLMS B; WERNER J; CREUTZFELDT W; ORSKOV C; HOLST JJ; NAUCK M
    INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE-PEPTIDE (7-36) AMIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    Diabetologia
    
    B. Willms et al., "INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE-PEPTIDE (7-36) AMIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS", Diabetologia, 37, 1994, pp. 10000118-10000118
49. ORSKOV C; RABENHOJ L; WETTERGREN A; KOFOD H; HOLST JJ
    TISSUE AND PLASMA-CONCENTRATIONS OF AMIDATED AND GLYCINE-EXTENDED GLUCAGON-LIKE PEPTIDE-I IN HUMANS
    Diabetes
    
    C. Orskov et al., "TISSUE AND PLASMA-CONCENTRATIONS OF AMIDATED AND GLYCINE-EXTENDED GLUCAGON-LIKE PEPTIDE-I IN HUMANS", Diabetes, 43(4), 1994, pp. 535-539
50. WILLMS B; WERNER J; CREUTZFELDT W; ORSKOV C; HOLST JJ; NAUCK M
    INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDEIN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    Diabetes
    
    B. Willms et al., "INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDEIN PATIENTS WITH TYPE-2 DIABETES-MELLITUS", Diabetes, 43, 1994, pp. 10000230-10000230
51. NIELSEN FC; ORSKOV C; HASELBACHER G; RAMLAU J; CHRISTIANSEN J; SCHMIEGELOW K; REHFELD JF
    INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER
    Cancer
    
    F.C. Nielsen et al., "INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER", Cancer, 73(4), 1994, pp. 1312-1319
52. NAUCK MA; BUSING M; ORSKOV C; SIEGEL EG; TALARTSCHIK J; BAARTZ A; BAARTZ T; HOPT UT; BECKER HD; CREUTZFELDT W
    PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION
    Acta diabetologica
    
    M.A. Nauck et al., "PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION", Acta diabetologica, 30(1), 1993, pp. 39-45
53. GOKE B; GOKE R; HOLST JJ; ORSKOV C
    GLUCAGON-LIKE PEPTIDE-1 - ON ITS WAY TO CLINICAL-APPLICATION
    Digestion
    
    B. Goke et al., "GLUCAGON-LIKE PEPTIDE-1 - ON ITS WAY TO CLINICAL-APPLICATION", Digestion, 54(6), 1993, pp. 339-340
54. ORSKOV C; WETTERGREN A; RABENHOJ L; HOLST JJ
    A COMPARISON OF THE PRODUCTION, SECRETION AND EFFECTS OF GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE AND GLP-1(7-37)
    Digestion
    
    C. Orskov et al., "A COMPARISON OF THE PRODUCTION, SECRETION AND EFFECTS OF GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE AND GLP-1(7-37)", Digestion, 54(6), 1993, pp. 382-383
55. HOLST JJ; HVIDBERG A; NIELSEN MT; HILSTED J; ORSKOV C
    EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GLUCOSE-TURNOVER IN NORMAL MAN
    Digestion
    
    J.J. Holst et al., "EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GLUCOSE-TURNOVER IN NORMAL MAN", Digestion, 54(6), 1993, pp. 383-384
56. WETTERGREN A; SCHJOLDAGER B; MORTENSEN PE; PETERSEN H; ORSKOV C; HOLST JJ
    EFFECT OF GLP-1 ON GASTRIC-MOTILITY AND GASTRIC AND PANCREATIC-SECRETION IN MAN
    Digestion
    
    A. Wettergren et al., "EFFECT OF GLP-1 ON GASTRIC-MOTILITY AND GASTRIC AND PANCREATIC-SECRETION IN MAN", Digestion, 54(6), 1993, pp. 384-385
57. MIHOLIC J; ORSKOV C; HOLST JJ; SCHAPER S
    POSTPRANDIAL GLP-1 IN PATIENTS AFTER ESOPHAGEAL RESECTION, TOTAL GASTRECTOMY AND MASSIVE SMALL-BOWEL RESECTION
    Digestion
    
    J. Miholic et al., "POSTPRANDIAL GLP-1 IN PATIENTS AFTER ESOPHAGEAL RESECTION, TOTAL GASTRECTOMY AND MASSIVE SMALL-BOWEL RESECTION", Digestion, 54(6), 1993, pp. 386-388
58. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
    NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    Digestion
    
    M.A. Nauck et al., "NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS", Digestion, 54(6), 1993, pp. 389-389
59. MIHOLIC J; ORSKOV C; HOLST JJ; KOTZERKE J; PICHLMAYR R
    POSTPRANDIAL RELEASE OF GLUCAGON-LIKE PEPTIDE-1, PANCREATIC GLUCAGON,AND INSULIN AFTER ESOPHAGEAL RESECTION
    Digestion
    
    J. Miholic et al., "POSTPRANDIAL RELEASE OF GLUCAGON-LIKE PEPTIDE-1, PANCREATIC GLUCAGON,AND INSULIN AFTER ESOPHAGEAL RESECTION", Digestion, 54(2), 1993, pp. 73-78
60. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
    NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    Diabetologia
    
    M.A. Nauck et al., "NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS", Diabetologia, 36(8), 1993, pp. 741-744
61. WILLMS B; KLEINE N; ORSKOV C; HOLST JJ; NAUCK MA; CREUTZFELDT W
    NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 (7-36 AMIDE) IN TYPE-2-DIABETIC
    Diabetologia
    
    B. Willms et al., "NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 (7-36 AMIDE) IN TYPE-2-DIABETIC", Diabetologia, 36, 1993, pp. 10000047-10000047
62. NAUCK MA; FIESELER P; ORSKOV C; HOLST JJ; NUSTEDE R; MARTELL J
    INSULINOTROPIC ACTIONS OF GIP AND GLP-1 (7-36 AMIDE), BUT NOT OF CCK-8 AT PHYSIOLOGICALLY ELEVATED AMINO-ACID-CONCENTRATIONS
    Diabetologia
    
    M.A. Nauck et al., "INSULINOTROPIC ACTIONS OF GIP AND GLP-1 (7-36 AMIDE), BUT NOT OF CCK-8 AT PHYSIOLOGICALLY ELEVATED AMINO-ACID-CONCENTRATIONS", Diabetologia, 36, 1993, pp. 10000048-10000048
63. HEINZE E; CLARK PMS; HALES CN; ORSKOV C; EBERT W; HOLL RW
    REDUCED GIP CONTRIBUTES TO ALTERED INSULIN-RESPONSE FOLLOWING ORAL GLUCOSE IN WOMEN WITH TURNER SYNDROME
    Diabetologia
    
    E. Heinze et al., "REDUCED GIP CONTRIBUTES TO ALTERED INSULIN-RESPONSE FOLLOWING ORAL GLUCOSE IN WOMEN WITH TURNER SYNDROME", Diabetologia, 36, 1993, pp. 10000048-10000048
64. ORSKOV C; WETTERGREN A; HOLST JJ
    BIOLOGICAL EFFECTS AND METABOLIC RATES OF GLUCAGON-LIKE PEPTIDE-1 7-36 AMIDE AND GLUCAGON-LIKE PEPTIDE-1 7-37 IN HEALTHY-SUBJECTS ARE INDISTINGUISHABLE
    Diabetes
    
    C. Orskov et al., "BIOLOGICAL EFFECTS AND METABOLIC RATES OF GLUCAGON-LIKE PEPTIDE-1 7-36 AMIDE AND GLUCAGON-LIKE PEPTIDE-1 7-37 IN HEALTHY-SUBJECTS ARE INDISTINGUISHABLE", Diabetes, 42(5), 1993, pp. 658-661
65. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
    NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 [7-36 AMIDE] IN TYPE-2-DIABETIC PATIENTS
    Diabetes
    
    M.A. Nauck et al., "NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 [7-36 AMIDE] IN TYPE-2-DIABETIC PATIENTS", Diabetes, 42, 1993, pp. 36-36
66. KARLSEN C; ORSKOV C; ROUILLE Y; WESTERMARK G; NIELSEN E; STEINER DF; HOLST JJ; MADSEN OD
    ARE PROPROTEIN CONVERTASES PC2 AND PC3 INVOLVED IN PROGLUCAGON PROCESSING
    Diabetes
    
    C. Karlsen et al., "ARE PROPROTEIN CONVERTASES PC2 AND PC3 INVOLVED IN PROGLUCAGON PROCESSING", Diabetes, 42, 1993, pp. 112-112